Literature DB >> 18032064

Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli.

Dong-Hyun Kim1, Keon-Hee Kim, Emre M Isin, F Peter Guengerich, Ho Zoon Chae, Taeho Ahn, Chul-Ho Yun.   

Abstract

In this study, wild-type human CYP1A2 without the conventional N-terminal modification (second codon GCT) or the truncation of the N-terminal hydrophobic region was functionally expressed in Escherichia coli. Its enzymatic properties were compared with N-terminally modified CYP1A2. Although modified CYP1A2 is almost all high-spin, some wild-type CYP1A2 shifted to low-spin. Spectral binding titrations with several ligands could be performed with wild-type enzyme, but not with modified enzyme. Kinetic parameters for several substrates were similar for the two CYP1A2 enzymes. However, the oxidation rates of phenacetin by modified enzyme were approximately 2-fold higher than those by wild-type enzyme. The intermolecular isotope effects were approximately 2 for phenacetin O-deethylation catalyzed by both enzymes. However, the wild-type enzyme, but not the modified enzyme, increased C-hydroxylation when O-deethylation rates were lowered by deuterium substitution. Molecular switching indicates that phenacetin rotates within the active site of wild-type enzyme and suggests a looser conformation in the active site of the wild-type enzyme than of the modified enzyme. These results reveal that the overall enzymatic properties of wild-type CYP1A2 enzyme are quite similar to those of modified CYP1A2, although its active site environment seems to differ from that of the modified enzyme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032064     DOI: 10.1016/j.pep.2007.10.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol.

Authors:  Don-Kyu Kim; Yong-Hoon Kim; Hyun-Hee Jang; Jinyoung Park; Jung Ran Kim; Minseob Koh; Won-Il Jeong; Seung-Hoi Koo; Tae-Sik Park; Chul-Ho Yun; Seung Bum Park; John Y L Chiang; Chul-Ho Lee; Hueng-Sik Choi
Journal:  Gut       Date:  2012-09-29       Impact factor: 23.059

2.  Comparison of microbial hosts and expression systems for mammalian CYP1A1 catalysis.

Authors:  Sjef Cornelissen; Mattijs K Julsing; Andreas Schmid; Bruno Bühler
Journal:  J Ind Microbiol Biotechnol       Date:  2011-08-24       Impact factor: 3.346

3.  Carbon-carbon bond cleavage in activation of the prodrug nabumetone.

Authors:  Fatbardha Varfaj; Siti N A Zulkifli; Hyoung-Goo Park; Victoria L Challinor; James J De Voss; Paul R Ortiz de Montellano
Journal:  Drug Metab Dispos       Date:  2014-02-28       Impact factor: 3.922

4.  Directed evolution reveals requisite sequence elements in the functional expression of P450 2F1 in Escherichia coli.

Authors:  James B Y H Behrendorff; Chad D Moore; Keon-Hee Kim; Dae-Hwan Kim; Christopher A Smith; Wayne A Johnston; Chul-Ho Yun; Garold S Yost; Elizabeth M J Gillam
Journal:  Chem Res Toxicol       Date:  2012-08-29       Impact factor: 3.739

5.  Functional studies of N-terminally modified CYP2J2 epoxygenase in model lipid bilayers.

Authors:  Daniel R McDougle; Amrita Palaria; Eric Magnetta; Daryl D Meling; Aditi Das
Journal:  Protein Sci       Date:  2013-07       Impact factor: 6.725

6.  Characterization of diverse natural variants of CYP102A1 found within a species of Bacillus megaterium.

Authors:  Ji-Yeon Kang; So-Young Kim; Dooil Kim; Dong-Hyun Kim; Sun-Mi Shin; Sun-Ha Park; Keon-Hee Kim; Heung-Chae Jung; Jae-Gu Pan; Young Hee Joung; Youn-Tae Chi; Ho Zoon Chae; Taeho Ahn; Chul-Ho Yun
Journal:  AMB Express       Date:  2011-03-28       Impact factor: 3.298

7.  Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.

Authors:  Paul Quehl; Joel Hollender; Jan Schüürmann; Tatjana Brossette; Ruth Maas; Joachim Jose
Journal:  Microb Cell Fact       Date:  2016-02-02       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.